These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 1973183)

  • 1. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
    Tan P; Anasetti C; Martin PJ; Hansen JA
    J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo ultraviolet-exposed human epidermal cells activate T suppressor cell pathways that involve CD4+CD45RA+ suppressor-inducer T cells.
    Baadsgaard O; Salvo B; Mannie A; Dass B; Fox DA; Cooper KD
    J Immunol; 1990 Nov; 145(9):2854-61. PubMed ID: 1976706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for the induction of allospecific CD8+ suppressor T cells in the rat primary mixed lymphocyte response. CD4+, CD45R+ T cells, or supernatant factor.
    Frankel AH; Sayegh MH; Rothstein DM; Milford EL; Carpenter CB
    Transplantation; 1989 Oct; 48(4):639-46. PubMed ID: 2572083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
    Damle NK; Childs AL; Doyle LV
    J Immunol; 1987 Sep; 139(5):1501-8. PubMed ID: 2887618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies.
    Sohen S; Rothstein DM; Tallman T; Gaudette D; Schlossman SF; Morimoto C
    Cell Immunol; 1990 Jun; 128(1):314-28. PubMed ID: 1693101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Con A-induced suppressor cell function depends on the activation of the CD4+CD45RA inducer T cell subpopulation.
    Sleasman JW; Henderson M; Barrett DJ
    Cell Immunol; 1991 Apr; 133(2):367-78. PubMed ID: 1826637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation.
    Akbar AN; Amlot PL; Timms A; Lombardi G; Lechler R; Janossy G
    Clin Exp Immunol; 1990 Aug; 81(2):225-31. PubMed ID: 1974831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. I. Differential helper cell requirement for the generation of cytotoxic effector cells from CD8+ precursor subpopulations.
    Bass HZ; Yamashita N; Clement LT
    J Immunol; 1992 Oct; 149(7):2489-95. PubMed ID: 1388193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.
    Cassell D; Forman J
    J Immunol; 1991 Jan; 146(1):3-10. PubMed ID: 1670605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressor-inducer T cells of B cell differentiation in man.
    Kansas GS; Engleman EG
    Eur J Immunol; 1987 Apr; 17(4):453-7. PubMed ID: 2952513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific suppressor T lymphocytes in man.
    Damle NK; Engleman EG
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S17-24. PubMed ID: 2551552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
    Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate.
    Clement LT; Vink PE; Bradley GE
    J Immunol; 1990 Jul; 145(1):102-8. PubMed ID: 1694200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoidosis is not associated with a generalized defect in T cell suppressor function.
    Saltini C; Spurzem JR; Kirby MR; Crystal RG
    J Immunol; 1988 Mar; 140(6):1854-60. PubMed ID: 2964485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
    Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation.
    Torimoto Y; Rothstein DM; Dang NH; Schlossman SF; Morimoto C
    J Immunol; 1992 Jan; 148(2):388-96. PubMed ID: 1345920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome.
    Stachowski J; Barth C; Michałkiewicz J; Krynicki T; Jarmoliński T; Runowski D; Lewandowska-Stachowiak M; Zaniew M; Warzywoda A; Bortkiewicz E; Dobosz M; Maciejewski J; Baldamus CA
    Pediatr Nephrol; 2000 Aug; 14(8-9):779-85. PubMed ID: 10955927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.